#151213

Anti-HGF/SF [EGH2 4C12.1]

Cat. #151213

Anti-HGF/SF [EGH2 4C12.1]

Cat. #: 151213

Sub-type: Primary antibody

Unit size: 100 ug

Availability: 1-2 weeks

Target: Hepatocyte Growth Factor/Scatter Factor (HGF/SF)

Class: Monoclonal

Application: ELISA ; WB ; ELISA ; IHC ; WB

Reactivity: Human

Host: Mouse

£300.00

This fee is applicable only for non-profit organisations. If you are a for-profit organisation or a researcher working on commercially-sponsored academic research, you will need to contact our licensing team for a commercial use license.

Contributor

Institute: University of Cambridge

Tool Details
Target Details
Applications
Handling
References

Tool Details

*FOR RESEARCH USE ONLY

  • Name: Anti-HGF/SF [EGH2 4C12.1]
  • Clone: EGH2 4C12.1
  • Tool sub type: Primary antibody
  • Class: Monoclonal
  • Conjugation: Unconjugated
  • Reactivity: Human
  • Host: Mouse
  • Application: ELISA ; WB ; ELISA ; IHC ; WB
  • Description: HGF/SF is a member of the plasminogen related growth factor family, members of which are potent effectors of growth, movement and differentiation of epithelial and endothelial cells. HGF/SF may exhibit morphogenesis in adjacent cells. The membrane receptor for HGF/SF is the product of the proto-oncogene c-met, a receptor tyrosine kinase.
  • Immunogen: Recombinant Human HGF/SF
  • Isotype: IgG2b
  • Myeloma used: NS0
  • Recommended controls: Recombinant HGF/SF

Target Details

  • Target: Hepatocyte Growth Factor/Scatter Factor (HGF/SF)
  • Tissue cell line specificity: Recombinant HGF/SF
  • Target background: HGF/SF is a member of the plasminogen related growth factor family, members of which are potent effectors of growth, movement and differentiation of epithelial and endothelial cells. HGF/SF may exhibit morphogenesis in adjacent cells. The membrane receptor for HGF/SF is the product of the proto-oncogene c-met, a receptor tyrosine kinase.

Applications

  • Application: ELISA ; WB ; ELISA ; IHC ; WB

Handling

  • Format: Liquid
  • Concentration: 1 mg/ml
  • Unit size: 100 ug
  • Storage buffer: PBS with 0.02% azide
  • Storage conditions: -15° C to -25° C
  • Shipping conditions: Shipping at 4° C

References

  • Clinical analysis of the effect of anti-allergy treatment on pocket-related complications following pacemaker implantation
  • Bai et al. 2017. Exp Ther Med. 13(6):2876-2882. PMID: 28587353.
  • In vitro and in vivo bioactivity of recombinant canine hepatocyte growth factor
  • Arends et al. 2008. Vet J. 178(1):70-7. PMID: 18314358.